Atorvastatin Calcium
Product Images NDC 68071-3602

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3602 3)

Label for Atorvastatin Calcium 10 mg tablets by NuCare Pharmaceuticals, Inc. The label states a quantity of 30 tablets per package and indicates the product is Rx only. It includes manufacturing and packaging details, dosage instructions, and warnings to keep out of reach of children. Storage temperature and lot information are also noted.*

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium, displaying its molecular arrangement including aromatic rings, hydroxyl groups, and calcium ion complexed with water molecules.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph showing cumulative incidence over time (in years) comparing Atorvastatin and Placebo groups. The graph displays two curves, with Atorvastatin represented by a solid line and Placebo by a dotted line, demonstrating different incidence trends up to 3.5 years.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line graph comparing cumulative hazard percentages over five years between two groups: placebo and atorvastatin. The x-axis represents time to first primary endpoint from one to five years of follow-up. The y-axis shows cumulative hazard percentage from 0 to 15%. The graph includes a hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and a p-value of 0.001.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A line graph depicting time to first major cardiovascular endpoint over five years for atorvastatin 10 mg and 80 mg doses. The y-axis shows the percentage of subjects experiencing events. The chart includes a hazard ratio (HR) of 0.78 with a confidence interval and a p-value, comparing outcomes between the two doses.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.